Modulation of Toll-like receptor ligands and Candida albicans-induced cytokine responses by specific probiotics

Cytokine

Volumn 59, Issue 1, 2012, Pages 159-165

  Plantinga, Theo S ^a   van Bergenhenegouwen, Jeroen ^b   Jacobs, Cor ^a   Joosten, Leo A B ^a   van't Land, Belinda ^b,c   Garssen, Johan ^b,c   Netea, Mihai G ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b DANONE RESEARCH   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

Author keywords

Candida albicans; Cytokines; Immune tolerance; Pattern recognition receptors; Probiotics

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; PATTERN RECOGNITION RECEPTOR; PROBIOTIC AGENT; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; BACTERIAL STRAIN; BIFIDOBACTERIUM BREVE; CANDIDA ALBICANS; CONTROLLED STUDY; CROSS TOLERANCE; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

BIFIDOBACTERIUM; CANDIDA ALBICANS; CYTOKINES; HUMANS; IMMUNE TOLERANCE; INTRACELLULAR SPACE; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS; LIGANDS; NOD2 SIGNALING ADAPTOR PROTEIN; PROBIOTICS; PROTEIN KINASE INHIBITORS; PROTEIN KINASES; RECEPTORS, PATTERN RECOGNITION; TOLL-LIKE RECEPTORS;

BIFIDOBACTERIUM; BIFIDOBACTERIUM BREVE; CANDIDA ALBICANS; FUNGI; LACTOBACILLUS; LACTOBACILLUS CASEI; LACTOBACILLUS RHAMNOSUS;

EID: 84861692151     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.03.020     Document Type: Article

References (30)

1. Macdonald T.T., Monteleone I., Fantini M.C., Monteleone G. Regulation of homeostasis and inflammation in the intestine. Gastroenterology 2011, 140:1768-1775.
2. Ballal S.A., Gallini C.A., Segata N., Huttenhower C., Garrett W.S. Host and gut microbiota symbiotic factors: lessons from inflammatory bowel disease and successful symbionts. Cell Microbiol 2011, 13:508-517.
3. Israeli E., Grotto I., Gilburd B., Balicer R.D., Goldin E., Wiik A., et al. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease. Gut 2005, 54:1232-1236.
4. Quinton J.F., Sendid B., Reumaux D., Duthilleul P., Cortot A., Grandbastien B., et al. Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 1998, 42:788-791.
5. Standaert-Vitse A., Jouault T., Vandewalle P., Mille C., Seddik M., Sendid B., et al. Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 2006, 130:1764-1775.
6. Dassopoulos T., Frangakis C., Cruz-Correa M., Talor M.V., Burek C.L., Datta L., et al. Antibodies to Saccharomyces cerevisiae in Crohn's disease: higher titers are associated with a greater frequency of mutant NOD2/CARD15 alleles and with a higher probability of complicated disease. Inflamm Bowel Dis 2007, 13:143-151.
7. Dassopoulos T., Nguyen G.C., Talor M.V., Datta L.W., Isaacs K.L., Lewis J.D., et al. NOD2 mutations and anti-Saccharomyces cerevisiae antibodies are risk factors for Crohn's disease in African Americans. Am J Gastroenterol 2010, 105:378-386.
8. Russell R.K., Ip B., Aldhous M.C., MacDougall M., Drummond H.E., Arnott I.D., et al. Anti-Saccharomyces cerevisiae antibodies status is associated with oral involvement and disease severity in Crohn' disease. J Pediatr Gastroenterol Nutr 2009, 48:161-167.
9. Standaert-Vitse A., Sendid B., Joossens M., Francois N., Vandewalle-El K.P., Branche J., et al. Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol 2009, 104:1745-1753.
10. Gorbach S.L. Probiotics and gastrointestinal health. Am J Gastroenterol 2000, 95:S2-S4.
11. Braat H., Van den B.J., Van T.E., Hommes D., Peppelenbosch M., van D.S. Lactobacillus rhamnosus induces peripheral hyporesponsiveness in stimulated CD4+ T cells via modulation of dendritic cell function. Am J Clin Nutr 2004, 80:1618-1625.
12. Imaoka A., Shima T., Kato K., Mizuno S., Uehara T., Matsumoto S., et al. Anti-inflammatory activity of probiotic Bifidobacterium: enhancement of IL-10 production in peripheral blood mononuclear cells from ulcerative colitis patients and inhibition of IL-8 secretion in HT-29 cells. World J Gastroenterol 2008, 14:2511-2516.
13. Lorea B.M., Kirjavainen P.V., Hekmat S., Reid G. Anti-inflammatory effects of probiotic yogurt in inflammatory bowel disease patients. Clin Exp Immunol 2007, 149:470-479.
14. Schultz M., Linde H.J., Lehn N., Zimmermann K., Grossmann J., Falk W., et al. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in healthy volunteers. J Dairy Res 2003, 70:165-173.
15. Wada M., Nagata S., Saito M., Shimizu T., Yamashiro Y., Matsuki T., et al. Effects of the enteral administration of Bifidobacterium breve on patients undergoing chemotherapy for pediatric malignancies. Support Care Cancer 2010, 18:751-759.
16. Manzoni P., Mostert M., Leonessa M.L., Priolo C., Farina D., Monetti C., et al. Oral supplementation with Lactobacillus casei subspecies rhamnosus prevents enteric colonization by Candida species in preterm neonates: a randomized study. Clin Infect Dis 2006, 42:1735-1742.
17. Martinez R.C., Seney S.L., Summers K.L., Nomizo A., De Martinis E.C., Reid G. Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation. Microbiol Immunol 2009, 53:487-495.
18. Zwolinska-Wcislo M., Brzozowski T., Mach T., Budak A., Trojanowska D., Konturek P.C., et al. Are probiotics effective in the treatment of fungal colonization of the gastrointestinal tract? Experimental and clinical studies. J Physiol Pharmacol 2006, 57(Suppl. 9):35-49.
19. O'Neill L.A., Bowie A.G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol 2007, 7:353-364.
20. Plantinga T.S., van Maren W.W., Van B.J., Hameetman M., Nierkens S., Jacob C., et al. Differential Toll-like receptor recognition and induction of cytokine profile by Bifidobacterium breve and Lactobacillus strains of probiotics. Clin Vaccine Immunol 2011, 18:621-628.
21. Popa C., Bdollahi-Roodsaz S., Joosten L.A., Takahashi N., Sprong T., Matera G., et al. Bartonella quintana lipopolysaccharide is a natural antagonist of Toll-like receptor 4. Infect Immun 2007, 75:4831-4837.
22. Agrawal S., Agrawal A., Doughty B., Gerwitz A., Blenis J., Van D.T., et al. Cutting edge: different Toll-like receptor agonists instruct dendritic cells to induce distinct Th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-Fos. J Immunol 2003, 171:4984-4989.
23. Dillon S., Agrawal A., Van D.T., Landreth G., McCauley L., Koh A., et al. A Toll-like receptor 2 ligand stimulates Th2 responses in vivo, via induction of extracellular signal-regulated kinase mitogen-activated protein kinase and c-Fos in dendritic cells. J Immunol 2004, 172:4733-4743.
24. Re F., Strominger J.L. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J Biol Chem 2001, 276:37692-37699.
25. Redecke V., Hacker H., Datta S.K., Fermin A., Pitha P.M., Broide D.H., et al. Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma. J Immunol 2004, 172:2739-2743.
26. Seiderer J., Elben I., Diegelmann J., Glas J., Stallhofer J., Tillack C., et al. Role of the novel Th17 cytokine IL-17F in inflammatory bowel disease (IBD): upregulated colonic IL-17F expression in active Crohn's disease and analysis of the IL17F p.His161Arg polymorphism in IBD. Inflamm Bowel Dis 2008, 14:437-445.
27. Van A.G., Vermeire S., Rutgeerts P. The potential for disease modification in Crohn's disease. Nat Rev Gastroenterol Hepatol 2010, 7:79-85.
28. Lee J.G., Lee S.H., Park D.W., Lee S.H., Yoon H.S., Chin B.R., et al. Toll-like receptor 9-stimulated monocyte chemoattractant protein-1 is mediated via JNK-cytosolic phospholipase A2-ROS signaling. Cell Signal 2008, 20:105-111.
29. Lee J., Mo J.H., Katakura K., Alkalay I., Rucker A.N., Liu Y.T., et al. Maintenance of colonic homeostasis by distinctive apical TLR9 signalling in intestinal epithelial cells. Nat Cell Biol 2006, 8:1327-1336.
30. Carol M., Borruel N., Antolin M., Llopis M., Casellas F., Guarner F., et al. Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease. J Leukoc Biol 2006, 79:917-922.